Author | Jae Park, MD | OncLive

Author | Jae Park, MD

Articles

Dr. Park on Ongoing Research Efforts With CAR T-Cell Therapies in ALL

April 02, 2020

Video

Jae Park, MD, a hematologist oncologist at Memorial Sloan Kettering Cancer Center, discusses the use of CAR T-cell therapies in patients with acute lymphocytic leukemia.

Dr. Park on CD19-Directed CAR T-Cell Therapy in Patients With ALL

April 06, 2018

Video

Jae Park, MD, hematologist oncologist, Memorial Sloan Kettering Cancer Center, discusses the potential of CD19-targeted chimeric antigen receptor (CAR) T-cell therapy in adult patients with acute lymphoblastic leukemia (ALL).

Dr. Park on Using CD19-Targeted CAR T Cells as Treatment for ALL

December 16, 2014

Video

Jae H. Park, MD, attending physician, Leukemia Service, Memorial Sloan Kettering Cancer Center, discusses a trial presented at the 2014 ASH Annual Meeting that explored CD19-targeted T cells as treatment for patients with relapsed, refractory B- cell ALL.

x